Prudential Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-51,558
| Closed | -$118K | – | 2655 |
|
|
2023
Q2 | $118K | Sell |
51,558
-49,600
| -49% | -$114K | ﹤0.01% | 2471 |
|
|
2023
Q1 | $246K | Buy |
101,158
+15,800
| +19% | +$38.4K | ﹤0.01% | 2333 |
|
|
2022
Q4 | $163K | Hold |
85,358
| – | – | ﹤0.01% | 2426 |
|
|
2022
Q3 | $205K | Sell |
85,358
-39,150
| -31% | -$94K | ﹤0.01% | 2442 |
|
|
2022
Q2 | $232K | Sell |
124,508
-44,500
| -26% | -$82.9K | ﹤0.01% | 2424 |
|
|
2022
Q1 | $353K | Sell |
169,008
-80,700
| -32% | -$169K | ﹤0.01% | 2335 |
|
|
2021
Q4 | $984K | Buy |
+249,708
| New | +$984K | ﹤0.01% | 1887 |
|
|
2021
Q1 | – | Sell |
-15,219
| Closed | -$52K | – | 2517 |
|
|
2020
Q4 | $52K | Buy |
15,219
+645
| +4% | +$2.2K | ﹤0.01% | 2408 |
|
|
2020
Q3 | $21K | Buy |
14,574
+2,805
| +24% | +$4.04K | ﹤0.01% | 2421 |
|
|
2020
Q2 | $23K | Buy |
11,769
+1,742
| +17% | +$3.4K | ﹤0.01% | 2381 |
|
|
2020
Q1 | $20K | Buy |
+10,027
| New | +$20K | ﹤0.01% | 2325 |
|
|
2016
Q4 | – | Sell |
-49,533
| Closed | -$895K | – | 2367 |
|
|
2016
Q3 | $895K | Buy |
+49,533
| New | +$895K | ﹤0.01% | 1848 |
|
|
2015
Q2 | – | Sell |
-27,223
| Closed | -$26K | – | 2245 |
|
|
2015
Q1 | $26K | Hold |
27,223
| – | – | ﹤0.01% | 2217 |
|
|
2014
Q4 | $25K | Buy |
27,223
+9,000
| +49% | +$8.27K | ﹤0.01% | 2185 |
|
|
2014
Q3 | $26K | Sell |
18,223
-17,801
| -49% | -$25.4K | ﹤0.01% | 2195 |
|
|
2014
Q2 | $58K | Buy |
36,024
+18,401
| +104% | +$29.6K | ﹤0.01% | 2378 |
|
|
2014
Q1 | $30K | Sell |
17,623
-900
| -5% | -$1.53K | ﹤0.01% | 2248 |
|
|
2013
Q4 | $33K | Sell |
18,523
-4,200
| -18% | -$7.48K | ﹤0.01% | 2266 |
|
|
2013
Q3 | $54K | Sell |
22,723
-3,800
| -14% | -$9.03K | ﹤0.01% | 2247 |
|
|
2013
Q2 | $58K | Buy |
+26,523
| New | +$58K | ﹤0.01% | 2248 |
|